SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has signed a definitive agreement to acquire Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio’s powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. With the addition of NextBio’s platform upon completion of the […]
With their participation in the completion of the largest cloud-based analysis of genome sequence data, researchers from the Baylor College of Medicine Human Genome Sequencing Center are helping to usher genomic scientists and clinicians around the world into a new era of high-level data analysis. (A “cloud” is a virtual network of remote internet servers […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School, has been authorized as a Certified Service Provider of Agilent’s next-generation target enrichment and microarray-based comparative genomic hybridization (aCGH) solutions. MEEI is home to the medical school’s Department of Ophthalmology Ocular […]
Boston/Leuven — Cartagenia, the world leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that more than 120 labs and clinics across three continents have now adopted and are relying on its Bench platform genetics diagnostics solution for use in daily […]
Los Gatos, CA — Annai Systems Inc., a genomic data management solution provider, today announced the broader availability of GTF use for license and download by authorized users of The Cancer Genome Atlas and TARGET data stored in CGHub. GTFuse is an innovative software application that speeds data analysis and enables researchers to more efficiently […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that The Centre for Genomic Research (CGR) at the University of Liverpool in the United Kingdom, has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. The CGR achieved certification to conduct next-generation sequencing target enrichment services with customer samples using the NimbleGen SeqCap EZ workflow. […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ: LIFE) today announced it has launched two breakthrough technologies under its new Ion Torrent Technology Access Program (TAP), an initiative designed to foster collaboration with the scientific community and drive innovation. Customers can get access to the Ion Hi-Q™ Sequencing Chemistry and the Ion Isothermal Amplification Chemistry at […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry’s leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling […]
New York City, New York; Redwood City, California, and Hilden, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that the Mount Sinai Genetic Testing Laboratory and the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai in New York City have adopted the Ingenuity® Variant Analysis™ solution for research and […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ: LIFE) today announced the inaugural Ion Torrent™ Breakthrough Award 2013 winner. The winning publication is “Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota,” published in the May 2013 edition of Nature. The paper’s first author, Ms. Anna Cebula, a graduate student of the Center for Biotechnology […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
